AR and neoplasm: Androgen receptor gene amplifications are uncommon in hormone-sensitive tumours and are present in 20–30% of hormone-resistant tumours (Visakorpi et al, 1995; Koivisto et al, 1997; Bubendorf et al, 1999; Miyoshi et al, 2000; Edwards et al, 2001).